| # | Side effect | Count |
|---|---|---|
| 0 | MALIGNANT NEOPLASM PROGRESSION | 4341 |
| 1 | FATIGUE | 4249 |
| 2 | NAUSEA | 3085 |
| 3 | DEATH | 2782 |
| 4 | DIARRHOEA | 2684 |
| 5 | NEUTROPENIA | 2542 |
| 6 | WHITE BLOOD CELL COUNT DECREASED | 2247 |
| 7 | METASTASES TO BONE | 2179 |
| 8 | NEOPLASM PROGRESSION | 2130 |
| 9 | ASTHENIA | 1812 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | PIK3CA-ACTIVATED MUTATION | 166 | 0.5000 |
| 1 | HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER | 132 | 0.3976 |
| 2 | CARBOHYDRATE ANTIGEN 15-3 INCREASED | 253 | 0.3325 |
| 3 | ELLIPTOCYTOSIS | 26 | 0.2889 |
| 4 | CARBOHYDRATE ANTIGEN 27.29 INCREASED | 38 | 0.2533 |
| 5 | INFUSION SITE COLDNESS | 24 | 0.2400 |
| 6 | PSEUDOCIRRHOSIS | 79 | 0.2380 |
| 7 | METASTASES TO THORAX | 47 | 0.1858 |
| 8 | METASTASES TO EYE | 39 | 0.1781 |
| 9 | PLEURAL NEOPLASM | 29 | 0.1758 |